Search clinical trials for: Pimecrolimus 1% Cream

Total 15365 results

Actavis Inc.

Completed

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Glenmark Pharmaceuticals Ltd. India

Completed

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Mylan Inc.
DPT Laboratories, Ltd.

Completed

Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Dominican Republic, Honduras
Technische Universität Dresden

Completed

Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis (OCT-AD)

Atopic Dermatitis

Germany
Par Pharmaceutical, Inc.

Completed

Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis
Technische Universität Dresden

Completed

Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound (OCT)

Healthy

Germany
University of Utah
Novartis

Completed

Pimecrolimus Cream for Oral Lichen Planus

Oral Lichen Planus

United States
Children's Hospital of Michigan
Novartis Pharmaceuticals

Terminated

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

Atopic Dermatitis
Dermavant Sciences GmbH

Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

Atopic Dermatitis

United States, Canada
Dermavant Sciences GmbH

Completed

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

Atopic Dermatitis

United States, Canada
GlaxoSmithKline

Completed

A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

Dermatitis, Atopic

United States, Canada, Japan
GlaxoSmithKline

Completed

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

Psoriasis

United States, Canada, Japan
GlaxoSmithKline
PPD; ERT: Clinical Trial Technology Solutions; Q2 Solutions

Withdrawn

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

Psoriasis
University of Parma

Completed

Foodprint 1.0: Physiological Acute Responses After Consumption of Confectionary Products (FP1)

Inflammatory Response | Endotoxemia | Oxidative Stress | Glucose, High Blood

Italy
GlaxoSmithKline
PPD; Innovaderm Research Inc.; iCardiac; Algorithme

Withdrawn

A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

Psoriasis
Mylan Inc.
Medicine Meda Pharmaceutical Information Consultancy (Beijing) Co., Ltd.

Completed

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

China
Novartis

Completed

Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis

Chronic Hand Dermatitis
Dermavant Sciences, Inc.

Recruiting

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Plaque Psoriasis

United States, Canada
Dermavant Sciences, Inc.

Completed

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Centre Hospitalier Universitaire de Nice

Terminated

Treatment of Oral Erosive Lichen Planus With Pimecrolimus Cream

Oral Erosive Lichen Planus
St Joseph University, Beirut, Lebanon

Unknown

Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba

Pityriasis Alba

Lebanon
Novartis

Completed

Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

Atopic Dermatitis

Germany
Novartis

Completed

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

Atopic Dermatitis

Philippines
Amazentis SA
proDERM GmbH

Completed

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

Skin Aging

Germany
Amazentis SA
proDERM GmbH

Completed

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

Erythema | Skin Inflammation | Sun Damaged Skin

Germany
Children's Hospital of Philadelphia
Novartis Pharmaceuticals

Completed

Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome

Netherton Syndrome

United States
Novartis

Completed

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Novartis

Completed

A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

Atopic Eczema

South Africa
Pfizer

Terminated

A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Atopic Dermatitis

United States, Poland, Germany, United Kingdom, Italy, Sweden, Switzerland
Zydus Worldwide DMCC
Catawba Research, LLC

Completed

Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea

Facial Rosacea

United States
LEO Pharma

Completed

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

Germany
Dermavant Sciences, Inc.

Completed

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

Psoriasis

United States
Betta Pharmaceuticals Co., Ltd.
Quintiles, Inc.

Completed

Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients

Psoriasis

New Zealand
DS Biopharma

Completed

Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)

Atopic Dermatitis

United States, Canada, South Africa
Amorepacific Corporation

Completed

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis

Atopic Dermatitis
Dermavant Sciences GmbH
IQVIA Biotech

Completed

Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

Plaque Psoriasis

United States, Canada
Dermavant Sciences, Inc.

Completed

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Dermavant Sciences GmbH

Completed

Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis

Plaque Psoriasis

United States
Frankel, Amylynne, M.D.
Onset Therapeutics, Inc

Completed

Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis

Eczema | Atopic Dermatitis

United States
Taro Pharmaceuticals USA

Completed

Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis

Tinea Pedis
Merz North America, Inc.

Completed

Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris

Tinea Cruris | Jock Itch

Belize, Dominican Republic, Honduras
Children's Hospital of Philadelphia
Novartis Pharmaceuticals

Completed

Combination Therapy for Atopic Dermatitis

Atopic Dermatitis

United States
Ceragenix Pharmaceuticals

Completed

Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Galderma R&D

Completed

Efficacy and Safety of CD5024 1% in Acne Vulgaris

Acne

France, Canada, Germany
Aldeyra Therapeutics, Inc.

Completed

RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

Sjogren-Larsson Syndrome

United States
University Hospital Muenster
Novartis Pharmaceuticals

Completed

Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease (CASM981CDE21)

Prurigo Nodularis

Germany
LEO Pharma

Completed

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

Atopic Dermatitis

Canada, Israel
Dermavant Sciences, Inc.

Completed

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

Psoriasis

United States
Soroka University Medical Center

Completed

Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study

Atopic Dermatitis

Israel
Shahid Beheshti University of Medical Sciences

Completed

Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus

Discoid Lupus Erythematosus

Iran, Islamic Republic of

3

Subscribe